×
0 0 0 0 0 0 0 0
Stockreport

Zafgen launches mid-stage study of ZGN-1061 in type 2 diabetics; shares ahead 5% after hours [Seeking Alpha]

ZAFGEN INC (ZFGN)  More Company Research Source: Seeking Alpha
Last zafgen inc earnings: 8/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: zafgen.gcs-web.com/investor-relations
PDF Zafgen launches mid-stage study of ZGN-1061 in type 2 diabetics; shares ahead 5% after hoursZafgen (NASDAQ:ZFGN)initiates a Phase 2 clinical trial assessing the ability of ZGN-1061 to control blood sugar levels in patients with type 2 diabetes. The 120-subject randomized placebo-controlled study will evaluate three doses of ZGN-1061 for 12 weeks in sites in Australia and New Zealand.Interim data should be available in H1 2018.ZGN-1061 is a fumagillin-class, injectable small molecule second generation MetAP2 inhibitor designed to improve glycemic control while helping to restore balance to fat metabolism. A fumagillin is an antimicrobial agent. MetAP2 is an enzyme that plays a key role tissue repair, angiogenesis and protein degradation and have demonstrated an ability to induce weight loss.Shares are up5% after hours but only on 118 shares.Now read:Gilead Stock In Revival Mode With Promising HIV Market And Stabilizing HCV Numbers » [Read more]

IMPACT SNAPSHOT EVENT TIME: ZFGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ZFGN alerts
from News Quantified